Kidney drug may reduce stone recurrence in cystinuria patients
19 Oct 2020
byJairia Dela Cruz
Dilutional therapy with tolvaptan favourably alters cystine saturation in the urine and increases urine output in patients with cystinuria, as shown in a small study, suggesting the drug’s potential in reducing the recurrence of stones in this population.
